BRIEF published on 06/26/2025 at 17:48, 7 months 3 days ago Dermapharm Holding SE Approves EUR 0.90 Dividend Per Share Sustainability Dividend AGM Financial Outlook Dermapharm
PRESS RELEASE published on 06/26/2025 at 17:43, 7 months 3 days ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.90 per share Dermapharm Holding SE's Annual General Meeting approves divident distribution of EUR 0.90 per share for 2024, confirms 2025 outlook and ratifies Board actions Annual General Meeting Financial Year 2024 Dividend Distribution Dermapharm Holding SE EUR 0.90 Per Share
BRIEF published on 05/15/2025 at 07:35, 8 months 14 days ago Dermapharm Holding SE répond aux attentes du premier trimestre 2025 et renforce ses prévisions pour l'ensemble de l'année Croissance Des Revenus Baisse De L'EBITDA Orientation Pour L'année Entière Produits Pharmaceutiques De Marque Dermapharm T1 2025
BRIEF published on 05/15/2025 at 07:35, 8 months 14 days ago Dermapharm Holding SE Meets Q1 2025 Expectations, Reinforces Full-Year Forecast Revenue Growth Full-year Guidance EBITDA Decline Branded Pharmaceuticals Dermapharm Q1 2025
PRESS RELEASE published on 05/15/2025 at 07:30, 8 months 14 days ago Dermapharm Holding SE performs in line with projections in Q1 2025, confirms full-year guidance Dermapharm Holding SE reports Q1 2025 results in line with projections, confirming full-year guidance. Revenue increases by 1.2% year-on-year to EUR 302.4 million Adjusted EBITDA Revenue Growth Dermapharm Holding SE Full-year Guidance Q1 2025 Results
BRIEF published on 03/28/2025 at 07:35, 10 months 1 day ago Les résultats financiers de Dermapharm en 2024 dépassent les attentes Augmentation Des Revenus Croissance De L'EBITDA Résultats Financiers 2024 Produits Pharmaceutiques De Marque Dermapharm
BRIEF published on 03/28/2025 at 07:35, 10 months 1 day ago Dermapharm's 2024 Financial Performance Exceeds Expectations Revenue Increase EBITDA Growth Branded Pharmaceuticals Financial Results 2024 Dermapharm
PRESS RELEASE published on 03/28/2025 at 07:30, 10 months 1 day ago Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance Dermapharm Holding SE reports successful financial year 2024 with increased revenue and exceeded EBITDA guidance. Full details in Annual Report Revenue Increase Financial Year 2024 EBITDA Guidance Annual Report Dermapharm Holding SE
BRIEF published on 03/14/2025 at 07:35, 10 months 15 days ago Dermapharm Holding SE augmente son chiffre d'affaires et dépasse les prévisions d'EBITDA Proposition De Dividende Produits De Santé Croissance De L'EBITDA Produits Pharmaceutiques De Marque Chiffre D'affaires De Dermapharm
BRIEF published on 03/14/2025 at 07:35, 10 months 15 days ago Dermapharm Holding SE Increases Revenue and Exceeds EBITDA Guidance Dividend Proposal EBITDA Growth Healthcare Products Branded Pharmaceuticals Dermapharm Revenue
Published on 01/30/2026 at 00:00, 1 hour 4 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 2 hours 4 minutes ago PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 6 hours 19 minutes ago Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 7 hours 4 minutes ago PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units
Published on 01/29/2026 at 17:00, 8 hours 4 minutes ago Sparta Reports on Delay in Filing Annual Financial Statements
Published on 01/30/2026 at 00:07, 56 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appointment of independent non-executive director
Published on 01/29/2026 at 21:02, 4 hours 1 minute ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 20:59, 4 hours 4 minutes ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 01/29/2026 at 20:57, 4 hours 6 minutes ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 01/29/2026 at 18:30, 6 hours 34 minutes ago ALPOU - Groupe POULAILLON chiffre d'affaires trimestriel T1 2025-2026 et Focus sur les activités
Published on 01/29/2026 at 18:00, 7 hours 4 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 18:00, 7 hours 4 minutes ago GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES CONSOLIDE ANNUEL 2025 : +2%
Published on 01/29/2026 at 17:45, 7 hours 19 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
